Charmandari E - Search Results

1

Plasma proteomic analysis in obese and overweight prepubertal children.

Galata Z, Moschonis G, Makridakis M, Dimitraki P, Nicolaides NC, Manios Y, Bartzeliotou A, Chrousos GP, Charmandari E. Galata Z, et al. Among authors: charmandari e. Eur J Clin Invest. 2011 Dec;41(12):1275-83. doi: 10.1111/j.1365-2362.2011.02536.x. Epub 2011 May 16. Eur J Clin Invest. 2011. PMID: 21569026

2

Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.

Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Charmandari E, et al. J Clin Endocrinol Metab. 2002 May;87(5):2114-20. doi: 10.1210/jcem.87.5.8456. J Clin Endocrinol Metab. 2002. PMID: 11994350

3

Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency.

Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP. Charmandari E, et al. J Clin Endocrinol Metab. 2002 Jul;87(7):3031-7. doi: 10.1210/jcem.87.7.8664. J Clin Endocrinol Metab. 2002. PMID: 12107196

4

Familial/sporadic glucocorticoid resistance syndrome and hypertension.

Kino T, Vottero A, Charmandari E, Chrousos GP. Kino T, et al. Among authors: charmandari e. Ann N Y Acad Sci. 2002 Sep;970:101-11. doi: 10.1111/j.1749-6632.2002.tb04416.x. Ann N Y Acad Sci. 2002. PMID: 12381545 Review.

5

Pediatric stress: hormonal mediators and human development.

Charmandari E, Kino T, Souvatzoglou E, Chrousos GP. Charmandari E, et al. Horm Res. 2003;59(4):161-79. doi: 10.1159/000069325. Horm Res. 2003. PMID: 12649570 Review.

6

Tissue glucocorticoid resistance/hypersensitivity syndromes.

Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP. Kino T, et al. Among authors: charmandari e. J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):457-67. doi: 10.1016/s0960-0760(03)00218-8. J Steroid Biochem Mol Biol. 2003. PMID: 12943736 Review.

7

Basic and clinical implications of glucocorticoid action--focus on development. National Institutes of Health, Bethesda, Maryland, USA. June 17-18, 2003. Introduction and abstracts.

Kino T, Charmandari E, Chrousos GP. Kino T, et al. Among authors: charmandari e. Horm Metab Res. 2003 Oct;35(10):628-48. doi: 10.1055/s-2003-43512-1. Horm Metab Res. 2003. PMID: 14606000 No abstract available.

8

Glucocorticoid action networks--an introduction to systems biology.

Chrousos GP, Charmandari E, Kino T. Chrousos GP, et al. Among authors: charmandari e. J Clin Endocrinol Metab. 2004 Feb;89(2):563-4. doi: 10.1210/jc.2003-032026. J Clin Endocrinol Metab. 2004. PMID: 14764762 No abstract available.

9

Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise.

Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Hiroi M, Eisenhofer G, Yanovski JA, Chrousos GP, Merke DP. Weise M, et al. Among authors: charmandari e. J Clin Endocrinol Metab. 2004 Feb;89(2):591-7. doi: 10.1210/jc.2003-030634. J Clin Endocrinol Metab. 2004. PMID: 14764767

10

Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.

Charmandari E, Kino T, Souvatzoglou E, Vottero A, Bhattacharyya N, Chrousos GP. Charmandari E, et al. J Clin Endocrinol Metab. 2004 Apr;89(4):1939-49. doi: 10.1210/jc.2003-030450. J Clin Endocrinol Metab. 2004. PMID: 15070967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters